Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Oncolytics Biotech Inc. has filed a Follow-on Equity Offerin

<< Previous

Bullboard Posts

Next >>

Comment by Angler101on Aug 04, 2024 10:00pm

84 Views

Post# 36164151

RE:RE:RE:RE:RE:RE:RE:RE:Oncolytics Biotech Inc. has filed a Follow-on Equity Offerin

Instead of trying to shut down free speech, like Azzak quite correctly stated, why don't you try to explain to me why you think it's better that Americans pay 20% more fore their groceries and 50% more for gas, and why you think we should allow 10 million more unvetted strangers into the country in the next four years, which will cost American taxpayers in the neighborhood of 3 4 hundred million dollars or more....(Mayor Adams of New York, in an interview on CNN, said that just the 20,000 new imigrants there will cost 2billion this year)........inquiring minds want to know!

<< Previous

Bullboard Posts

Next >>

Morning Market Outlook for Nov. 25, 2024